For Prof Moses Assignment

09/23/2015 1 Mergent, Inc.

Johnson & Johnson

General Company Information

Principal Office One Johnson & Johnson Plaza

New Brunswick, NJ 08933 USA

Phone 732 524-0400

Fax 732 214-0332

Auditor PricewaterhouseCoopers LLP

Number of Employees 126,500 (Approximate Full-Time as of 12/31/2014)

Country of Incorporation United States

Exchange And Ticker NYS : JNJ

Primary SIC 2834 : Pharmaceutical preparations

Company Website www.jnj.com

Primary NAICS 325412 : Pharmaceutical Preparation Manufacturing

Closing Stock Price 93.24 (as of 09/22/2015)

Incorporated November 1887 , NJ, United States

Mergent Dividend Achiever Yes, # of Years: 46

Number of Shareholders 162,062 (record) (as of 02/17/2015)

Business Summary

Johnson & Johnson is a holding company. Through its subsidiaries, Co. is organized into three segments. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopaedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care markets, which are distributed to wholesalers, hospitals and retailers.

Johnson & Johnson

09/23/2015 2 Mergent, Inc.

Pricing Information

Closing Price As of 09/22/2015 : 93.24

Dividend Yield 3.1103

Earning Per Share(TTM) 5.78

Dividend Per Share(TTM) 2.9

Market Cap(mil) 258,191

52 Week Range 90.73 - 109.07

PE Ratio 16.3866

% Price Change (100 Days) -4.36